The Journal of Urology
Volume 181, Issue 3 , Pages 1098-1103, March 2009

Lycopene for Advanced Hormone Refractory Prostate Cancer: A Prospective, Open Phase II Pilot Study

Departments of Urology and Paediatric Urology and Philipp-Klee-Institute for Clinical Pharmacology (PT), Witten/Herdecke University, Witten and Helios-Hospital of Wuppertal, Wuppertal, Germany

Received 21 July 2008 published online 15 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received Witten/Herdecke University ethics committee approval.

 Supported by the Bergisch Urologische Gesellschaft e. V. and Helios Kliniken GmbH, Berlin.

 For another article on a related topic see page 1393.

PII: S0022-5347(08)03039-5

doi:10.1016/j.juro.2008.11.012

Refers to article:

  • Increased Urokinase-Type Plasminogen Activator Receptor and Epidermal Growth Factor Receptor in Serum of Patients With Prostate Cancer , 20 January 2009

    Giulio Milanese, Marco Dellabella, Francesca Fazioli, Elisa Pierpaoli, Massimo Polito, Nicolai Siednius, Rodolfo Montironi, Francesco Blasi, Giovanni Muzzonigro
    The Journal of Urology March 2009 (Vol. 181, Issue 3, Pages 1393-1400)

The Journal of Urology
Volume 181, Issue 3 , Pages 1098-1103, March 2009

Article Tools

* Image Usage & Resolution